PetMed Express (PETS) to Release Earnings on Thursday

PetMed Express (NASDAQ:PETS - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $59.60 million for the quarter.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million during the quarter, compared to analyst estimates of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Stock Down 0.4 %

Shares of NASDAQ PETS traded down $0.02 during trading hours on Thursday, hitting $4.97. 143,817 shares of the stock were exchanged, compared to its average volume of 225,076. PetMed Express has a 12 month low of $2.90 and a 12 month high of $6.85. The firm has a fifty day moving average price of $5.08 and a 200-day moving average price of $4.25. The company has a market cap of $102.68 million, a PE ratio of -83.17 and a beta of 0.69.

Analyst Ratings Changes

Separately, StockNews.com upgraded PetMed Express from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th.

Insiders Place Their Bets

In other PetMed Express news, Director Leslie C.G. Campbell acquired 15,000 shares of the company's stock in a transaction dated Wednesday, December 4th. The shares were acquired at an average cost of $5.38 per share, with a total value of $80,700.00. Following the acquisition, the director now directly owns 70,000 shares of the company's stock, valued at approximately $376,600. The trade was a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 1.10% of the stock is currently owned by insiders.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.